These Big Pharma Stocks Lead Dow Losers
The Dow Jones Industrial Average (NYSEARCA:DIA) is down today by 0.22% and stands at 12,689. Here are some lower-performing stocks today.
Merck (NYSE:MRK) results were a mixed picture today, and 4Q sales disappointed, but what hurts the stock today is the forecast for 2012. The company’s biggest issue is that its allergy medication Singulair will expire in August, and generic competition is likely to take a significant chunk of that product’s revenues. MRK shares recently traded at $38.63, up $0.13, or 0.34%. They have traded in a 52-week range of $29.47 to $39.43. Volume today was 15,743,900 shares versus a 3-month average volume of 13,300,00 shares. The company’s trailing P/E is 1.37, while trailing earnings are $1.68 (4.40%) per share.
Pfizer (NYSE:PFE): A Canadian court has denied an appeal by Pfizer to protect Apotex from being used as a generic drug. The stock is performing even worse than Merck. PFE shares recently traded at $21.31, up $0.18, or 0.85%. They have traded in a 52-week range of $16.63 to $22.17. Volume today was 46,541,100 shares versus a 3-month average volume of 43,240,000 shares. The company’s trailing P/E is 1.44, while trailing earnings are $0.88 (4.10%) per share.
Hewlett Packard (NYSE:HPQ): A fire safety issues is forcing the recall of models 1040 and 1050. Apparently, electrical issues could cause serious issues in almost a million of these products. HPQ shares recently traded at $28.76, up $0.23, or 0.81%. They have traded in a 52-week range of $21.50 to $49.39. Volume today was 17,330,700 shares versus a 3-month average volume of 13,280,000 shares. The company’s trailing P/E is 3.32, while trailing earnings are $0.48 (1.70%) per share.
To contact the reporter on this story: Scott Gillette at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org